Malaria vaccine development paves way for protective therapy

Scientists have made a significant contribution towards the development of a vaccine to prevent malaria.

Researchers have tested a preliminary form of a against the disease, which is spread by the bite of the mosquito and kills more than 600,000 people each year.

Until now, developing malaria vaccines has been challenging. A vaccine must incorporate key proteins from the malaria parasites, which will trigger production of antibodies by the immune system. These proteins have a complex, intricate structure that is hard to reproduce.

Scientists at the University of Edinburgh have now found a novel way to produce proteins that could lead to malaria vaccines being easy and cheap to manufacture. They have grown them inside a tiny single-celled aquatic creature, whose biological make-up is similar to that of the malaria parasite. The organism, and the , can multiply quickly in the lab.

In tests in mice, a vaccine developed using human parasite proteins – known as MSP-1-BBM – enabled the immune system to produce antibodies in the bloodstream. These antibodies were shown to respond to the human , indicating that the vaccine would be likely to trigger an if it were used in people.

Researchers now hope to develop the vaccine for further testing, with the aim of producing a therapy that will be effective in humans. Scientists say there is a pressing need for new treatments, as many forms of the disease are becoming resistant to existing drugs. Children and pregnant women in sub-Saharan Africa are particularly at risk.

The study, carried out in collaboration with the German company Cilia AG and published in the journal PLoS One, was funded by the European Union.

Dr. David Cavanagh, of the University of Edinburgh's School of Biological Sciences, who led the study, said: "There is a desperate need for an effective vaccine, which can be made easily in large quantities, to protect against this devastating disease. Our findings meet this challenge and, with more work, could lead to a vaccine to help those most at risk."

add to favorites email to friend print save as pdf

Related Stories

Australian researchers close in on malaria vaccine

Jul 02, 2013

Australian researchers said Tuesday they were closing in on a potential vaccine against malaria, with a study showing their treatment had protected mice against several strains of the disease.

Recommended for you

US approves new, hard-to-abuse hydrocodone pill (Update)

Nov 20, 2014

U.S. government health regulators on Thursday approved the first hard-to-abuse version of the painkiller hydrocodone, offering an alternative to a similar medication that has been widely criticized for lacking ...

Soaring generic drug prices draw Senate scrutiny

Nov 20, 2014

Some low-cost generic drugs that have helped restrain health care costs for decades are seeing unexpected price spikes of up to 8,000 percent, prompting a backlash from patients, pharmacists and now Washington ...

Only half of patients take their medications as prescribed

Nov 20, 2014

The cost of patients not taking their medications as prescribed can be substantial in terms of their health. Although a large amount of research evidence has tried to address this problem, there are no well-established ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.